DOCSLIB.ORG

Notifiable Diseases and Their Respective Causative Pathogens File Size

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Notifiable Diseases and Their Respective Causative Pathogens File Size Notifiable Diseases and their respective causative pathogens specified to be Infectious Diseases under Infectious Diseases (Amendment) Regulations 2020 (S.I. No. 53 of 2020) February 2020 Disease Causative Pathogen Disease Causative Pathogen Acute anterior poliomyelitis Polio virus Measles Measles virus Ano-genital warts Human papilloma virus Meningococcal disease Neisseria meningitidis Anthrax Bacillus anthracis Mumps Mumps virus Bacillus cereus food-borne infection/intoxication Bacillus cereus Non-specific urethritis Bacterial meningitis (not otherwise specified) Novel or Rare Antimicrobial-resistant Botulism Clostridium botulinum Organism (NRAO) Brucellosis Brucella spp. Noroviral infection Norovirus Campylobacter infection Campylobacter spp. Paratyphoid Salmonella Paratyphi Carbapenemase producing Enterobacteriaceae, Carbapenemase producing Enterobacteriaceae, Pertussis Bordetella pertussis infection or colonisation infection or colonisation Plague Yersinia pestis Chancroid Haemophilus ducreyi Pseudomonas aeruginosa infection (invasive) Pseudomonas aeruginosa (blood or CSF) Chickenpox – hospitalised cases Varicella-zoster virus Q Fever Coxiella burnetii Chikungunya disease Chikungunya virus Rabies Rabies virus Chlamydia trachomatis infection (genital) Chlamydia trachomatis Respiratory syncytial virus infection Respiratory syncytial virus Cholera Vibrio cholerae Rotavirus infection Rotavirus Clostridium difficile infection Clostridium difficile Rubella Rubella virus Clostridium perfringens (type A) food-borne disease Clostridium perfringens Salmonellosis Salmonella spp. other than S. Typhi and COVID-19 SARS-CoV-2 S. Paratyphi Creutzfeldt Jakob disease Severe Acute Respiratory Syndrome (SARS) SARS-associated coronavirus variant Creutzfeldt Jakob disease Shigellosis Shigella spp. Cryptosporidiosis Cryptosporidium parvum, hominis Smallpox Variola virus Cytomegalovirus infection (congenital) Cytomegalovirus Staphylococcal food poisoning Enterotoxigenic Staphylococcus aureus Dengue fever Dengue virus Staphylococcus aureus bacteraemia Staphylococcus aureus (blood) Diphtheria Corynebacterium diphtheriae or ulcerans (toxin producing) Streptococcus group A infection (invasive) Streptococcus pyogenes (blood, CSF or other Echinococcosis Echinococcus spp. Enterococcal bacteraemia Enterococcus spp. (blood) normally sterile site) Escherichia coli infection (invasive) Escherichia coli (blood, CSF) Streptococcus group B infection (invasive) Streptococcus agalactiae (blood, CSF or other Giardiasis Giardia lamblia normally sterile site) Gonorrhoea Neisseria gonorrhoeae Streptococcus pneumoniae infection (invasive) Streptococcus pneumoniae (blood, CSF or other Granuloma inguinale Klebsiella granulomatis normally sterile site) Haemophilus influenzae disease (invasive) Haemophilus influenzae (blood, CSF or other Syphilis Treponema pallidum normally sterile site) Tetanus Clostridium tetani Hepatitis A (acute) infection Hepatitis A virus Toxoplasmosis Toxoplasma gondii Hepatitis B (acute and chronic) infection Hepatitis B virus Trichinosis Trichinella spp. Hepatitis C infection Hepatitis C virus Trichomoniasis Trichomonas vaginalis Hepatitis E infection Hepatitis E virus Tuberculosis Mycobacterium tuberculosis complex Herpes simplex (genital) Herpes simplex virus Tularemia Francisella tularensis Herpes simplex (neonatal) Herpes simplex virus Typhoid Salmonella Typhi Human immunodeficiency virus infection Human immunodeficiency virus Typhus Rickettsia prowazekii Influenza Influenza A and B virus Verotoxigenic Escherichia coli infection Verotoxin producing Escherichia coli Klebsiella pneumoniae infection (invasive) Klebsiella pneumoniae (blood or CSF) Viral encephalitis Legionellosis Legionella spp. Viral haemorrhagic fevers Leprosy Mycobacterium leprae Viral meningitis Leptospirosis Leptospira spp. West Nile fever West Nile virus Listeriosis Listeria monocytogenes Yellow fever Yellow fever virus Lyme disease (neuroborreliosis) Borrelia burgdorferi Yersiniosis Yersinia enterocolitica, Yersinia pseudotuberculosis Lymphogranuloma venereum Chlamydia trachomatis Zika virus infection Zika virus Malaria Plasmodium falciparum, vivax, knowlesi, ovale, malariae mcr-positive Enterobacteriaceae infection mcr-positive Enterobacteriaceae infection Please refer to the case definitions for the above diseases. The up-to-date list of diseases or colonisation or colonisation and case definitions are available on the HPSC website at www.hpsc.ie/notifiablediseases East North West South East Counties Dublin, Kildare and Wicklow County Donegal Counties Carlow, Medical Officer of Health, Medical Officer of Health, Kilkenny, South Tipperary, Waterford and Department of Public Health, Department of Public Health, Wexford Room G29, Iona House, Medical Officer of Health, Dr Steevens’ Hospital, Upper Main Street, Department of Public Health, Dublin 8. Ballyshannon, Lacken, Phone: 01 6352145 Co. Donegal. Dublin Road, Fax: 01 6352103 Phone: 071 9852900 Kilkenny. Fax: 071 9852901 Phone: 056 7784142 Fax: 056 7784599 Counties Sligo and Leitrim Midlands Medical Officer of Health, Counties Laois, Offaly, Longford and Department of Public Health, West Westmeath Bridgewater House, Counties Galway, Mayo and Roscommon Medical Officer of Health, Rockwood Parade, Medical Officer of Health, Department of Public Health, Sligo. Department of Public Health, Area Office, Phone: 071 9174750 Merlin Park Hospital, Arden Road, Fax: 071 9138335 Galway. Tullamore, Phone: 091 775200 Co. Offaly. Fax: 091 758283 Phone: 057 9359891 South Fax: 057 9359907 County Cork Medical Officer of Health, Department of Public Health, Mid West Floor 2, Block 8, Counties Clare, Limerick and North St Finbarr’s Hospital, Tipperary Douglas Road, Medical Officer of Health, Cork. Department of Public Health, Phone: 021 4927601 Mount Kennett House, Fax: 021 4923257 Henry Street, Limerick. Phone: 061 483337 County Kerry Fax: 061 464205 Medical Officer of Health, Department of Public Health, Rathass, North East Tralee, Co. Kerry. Counties Cavan, Louth, Meath and Phone: 066 7184548 Monaghan Fax: 066 7184542 Medical Officer of Health, Department of Public Health, Railway Street, Navan, Co. Meath. Phone: 046 9076412 Fax: 046 9072325.
Load more

Recommended publications
  • Café Au Lait Spots As a Marker of Neuropaediatric Diseases
    Mini Review Open Access J Neurol Neurosurg Volume 3 Issue 5 - May 2017 DOI: 10.19080/OAJNN.2017.03.555622 Copyright © All rights are reserved by Francisco Carratalá-Marco Café Au Lait Spots as a Marker of Neuropaediatric Diseases Francisco Carratalá-Marco1*, Rosa María Ruiz-Miralles2, Patricia Andreo-Lillo1, Julia Dolores Miralles-Botella3, Lorena Pastor-Ferrándiz1 and Mercedes Juste-Ruiz2 1Neuropaediatric Unit, University Hospital of San Juan de Alicante, Spain 2Paediatric Department, University Hospital of San Juan de Alicante, Spain 3Dermatology Department, University Hospital of San Juan de Alicante, Spain Submission: March 22, 2017; Published: May 10, 2017 *Corresponding author: Francisco Carratalá-Marco, Neuropaediatric Unit, University Hospital of San Juan de Alicante, Spain, Tel: ; Email: Abstract Introduction: want to know in which The measure,Café au lait the spots presence (CALS) of isolated are shown CALS in representsthe normal a population risk factor forwithout neurological pathological disease. significance, although they could also be criteria for some neurologic syndromes. Unspecific association with general neurologic illnesses has been less frequently described. We Patients and methods: We set up an observational transversal study of cases, patients admitted for neuropaediatric reasons (NPP; n=49) excluding all the patients suffering from neurologic illnesses associated to CALS, and controls, a hospital simultaneously admitted pediatric population for non-neurologic causes (CP; n=101) since October 2012 to January 2013. The data were collected from the clinical reports at admission, and then analyzed by SPSS 22.0 statistical package, and the Stat Calc module of EpiInfo 7.0, following the ethics current rules of the institution for observational studies.
    [Show full text]
  • History of the Development of the ICD
    History of the development of the ICD 1. Early history Sir George Knibbs, the eminent Australian statistician, credited François Bossier de Lacroix (1706-1777), better known as Sauvages, with the first attempt to classify diseases systematically (10). Sauvages' comprehensive treatise was published under the title Nosologia methodica. A contemporary of Sauvages was the great methodologist Linnaeus (1707-1778), one of whose treatises was entitled Genera morborum. At the beginning of the 19th century, the classification of disease in most general use was one by William Cullen (1710-1790), of Edinburgh, which was published in 1785 under the title Synopsis nosologiae methodicae. For all practical purposes, however, the statistical study of disease began a century earlier with the work of John Graunt on the London Bills of Mortality. The kind of classification envisaged by this pioneer is exemplified by his attempt to estimate the proportion of liveborn children who died before reaching the age of six years, no records of age at death being available. He took all deaths classed as thrush, convulsions, rickets, teeth and worms, abortives, chrysomes, infants, livergrown, and overlaid and added to them half the deaths classed as smallpox, swinepox, measles, and worms without convulsions. Despite the crudity of this classification his estimate of a 36 % mortality before the age of six years appears from later evidence to have been a good one. While three centuries have contributed something to the scientific accuracy of disease classification, there are many who doubt the usefulness of attempts to compile statistics of disease, or even causes of death, because of the difficulties of classification.
    [Show full text]
  • A Brief Evaluation and Image Formation of Pediatrics Nutritional Forum in Opinion Sector Disouja Wills* Nutritonal Sciences, Christian Universita Degli Studo, Italy
    d Pediatr Wills, Matern Pediatr Nutr 2016, 2:2 an ic l N a u n t DOI: 10.4172/2472-1182.1000113 r r e i t t i o Maternal and Pediatric a n M ISSN: 2472-1182 Nutrition ShortResearch Commentary Article OpenOpen Access Access A Brief Evaluation and Image formation of Pediatrics Nutritional Forum in Opinion Sector Disouja Wills* Nutritonal Sciences, Christian Universita degli studo, Italy Abstract Severe most and one of the main global threat is Nutritional disorders to backward countries, with respect to this issue WHO involved and trying to overcome this issue with the Co-ordination of INF and BNF. International Nutrition Foundation and British Nutrition Foundation, development in weight gain through proper nutrition and proper immune mechanism in the kids is their main role to eradicate and overcome nutritional problems in world. Keywords: INF; BNF; Malnutrition; Merasmus; Rickets; Weight loss; Precautions to Avoid Nutrition Deficiency in Paediatric health issue Paediatrics Introduction Respective disease having respective deficiency dis order but in the case of nutritional diseases. Proper nutrition is the only thing to cure In the mankind a respective one health and weight gain is fully nutritional disorders. Providing sufficient diet like fish, meat, egg, milk based on perfect nutritional intake which he is having daily, poor diet to malnourished kids and consuming beef, fish liver oil, sheep meat, will show the improper impact and injury to the some of the systems boiled eggs from the age of 3 itself (Tables 1 and 2). in the body, total health also in some times. Blindness, Scurvy, Rickets will be caused by nutritional deficiency disorders only, mainly in kids.
    [Show full text]
  • EFFECTIVE NEBRASKA DEPARTMENT of 01/01/2017 HEALTH and HUMAN SERVICES 173 NAC 1 I TITLE 173 COMMUNICABLE DISEASES CHAPTER 1
    EFFECTIVE NEBRASKA DEPARTMENT OF 01/01/2017 HEALTH AND HUMAN SERVICES 173 NAC 1 TITLE 173 COMMUNICABLE DISEASES CHAPTER 1 REPORTING AND CONTROL OF COMMUNICABLE DISEASES TABLE OF CONTENTS SECTION SUBJECT PAGE 1-001 SCOPE AND AUTHORITY 1 1-002 DEFINITIONS 1 1-003 WHO MUST REPORT 2 1-003.01 Healthcare Providers (Physicians and Hospitals) 2 1-003.01A Reporting by PA’s and APRN’s 2 1-003.01B Reporting by Laboratories in lieu of Physicians 3 1-003.01C Reporting by Healthcare Facilities in lieu of Physicians for 3 Healthcare Associated Infections (HAIs) 1-003.02 Laboratories 3 1-003.02A Electronic Ordering of Laboratory Tests 3 1-004 REPORTABLE DISEASES, POISONINGS, AND ORGANISMS: 3 LISTS AND FREQUENCY OF REPORTS 1-004.01 Immediate Reports 4 1-004.01A List of Diseases, Poisonings, and Organisms 4 1-004.01B Clusters, Outbreaks, or Unusual Events, Including Possible 5 Bioterroristic Attacks 1-004.02 Reports Within Seven Days – List of Reportable Diseases, 5 Poisonings, and Organisms 1-004.03 Reporting of Antimicrobial Susceptibility 8 1-004.04 New or Emerging Diseases and Other Syndromes and Exposures – 8 Reporting and Submissions 1-004.04A Criteria 8 1-004.04B Surveillance Mechanism 8 1-004.05 Sexually Transmitted Diseases 9 1-004.06 Healthcare Associated Infections 9 1-005 METHODS OF REPORTING 9 1-005.01 Health Care Providers 9 1-005.01A Immediate Reports of Diseases, Poisonings, and Organisms 9 1-005.01B Immediate Reports of Clusters, Outbreaks, or Unusual Events, 9 Including Possible Bioterroristic Attacks i EFFECTIVE NEBRASKA DEPARTMENT OF
    [Show full text]
  • Bioterrorism Diseases Annex Infectious Disease Emergency Response (IDER) Plan
    Bioterrorism Diseases Annex Infectious Disease Emergency Response (IDER) Plan Contents I Background IV Activation & Notification II Response Organization V Operational Guidance III Purpose & Objectives VI Resources I. BACKGROUND A bioterrorism event is defined for the purposes of this annex as the deliberate introduction of pathogenic microorganisms or their products (bacteria, viruses, fungi or toxins) into a community. Potential bioterrorism agents are categorized by the Centers for Disease Control and Prevention (CDC) by category. Category A agents (highest priority) include organisms that pose a risk to national security because they can be easily disseminated or transmitted from person-to-person; result in high mortality rates and have the potential for major public health impact; might cause public panic and social disruption; and require special action for public health preparedness. These include: • Anthrax (Bacillus anthracis) • Smallpox (variola major) • Botulism (Clostridium botulinum • Tularemia (Franciscella tularensis) toxin) • Viral Hemorrhagic Fevers (filoviruses, • Plague (Yersinia pestis) arenaviruses) Of second highest priority are category B agents which are organisms that are moderately easy to disseminate; that result in moderate morbidity rates and low mortality rates; and that require enhanced diagnostic capacity and disease surveillance. • Brucellosis (Brucella species)* • Epsilon toxin of Clostridium perfringens • Food safety threats (Salmonella species, Escherichia coli O157:H7, Shigella) • Glanders (Burkholderia
    [Show full text]
  • Whole Day Download the Hansard
    Tuesday Volume 597 30 June 2015 No. 25 HOUSE OF COMMONS OFFICIAL REPORT PARLIAMENTARY DEBATES (HANSARD) Tuesday 30 June 2015 £5·00 © Parliamentary Copyright House of Commons 2015 This publication may be reproduced under the terms of the Open Parliament licence, which is published at www.parliament.uk/site-information/copyright/. 1315 30 JUNE 2015 1316 Robert Flello (Stoke-on-Trent South) (Lab): I draw House of Commons attention to my entry in the register of interests. Many small and medium-sized freight businesses struggle with Tuesday 30 June 2015 the cost of training drivers. Have the Government any plans to look at this afresh with a view to helping people train to become lorry drivers in the UK? The House met at half-past Eleven o’clock Sajid Javid: As the hon. Gentleman will know, it is PRAYERS very important for the Government to listen to all industries about their skills and training needs, including for freight drivers. Of course, the option of apprenticeships [MR SPEAKER in the Chair] is open to that industry, but we must look at other measures too. BUSINESS BEFORE QUESTIONS Mike Wood (Dudley South) (Con): The business rates system is one of the major barriers to competitiveness CONTINGENCIES FUND 2014-15 for small and medium-sized enterprises. What plans do Ordered, Ministers have to reform and alleviate some of that That there be laid before this House an Account of the burden? Contingencies Fund, 2014–15, showing– (1) a Statement of Financial Position; Sajid Javid: My hon. Friend will know that the (2) a Statement of Cash Flows; and Chancellor announced a full review of business rates in (3) Notes to the Account; together with the Certificate and the last Budget.
    [Show full text]
  • Connecticut Insurance Coverage for Specialized Formula; New York's “Hannah's Law”
    OLR RESEARCH REPORT July 5, 2012 2012-R-0304 CONNECTICUT INSURANCE COVERAGE FOR SPECIALIZED FORMULA; NEW YORK'S “HANNAH'S LAW” By: Janet L. Kaminski Leduc, Senior Legislative Attorney You asked if Connecticut law requires health insurance policies to cover specialized formula used for treating eosinophilic disorder. You also asked for a description of New York’s “Hannah’s Law.” SUMMARY Connecticut insurance law does not explicitly require health insurance policies to cover specialized formulas for treating eosinophilic disorder. However, the law requires specified health insurance policies to cover medically necessary specialized formula for children up to age 12 for treating a disease or condition when the formula is administered under a physician’s direction. Thus, it appears that this would include coverage of specialized formulas for treating eosinophilic disorder. Anyone denied such coverage may appeal to their insurance carrier (internal appeal) or the Insurance Department (external appeal). The explanation of benefits from the carrier describes the appeal process. Anyone with concerns or questions about his or her insurance coverage may contact the Insurance Department’s Consumer Affairs Division at (800) 203-3447 or (860) 297-3900. More information about contacting the department is available at http://www.ct.gov/cid/cwp/view.asp?q=254352. Sandra Norman-Eady, Director Room 5300 Phone (860) 240-8400 Legislative Office Building FAX (860) 240-8881 Connecticut General Assembly Hartford, CT 06106-1591 http://www.cga.ct.gov/olr Office of Legislative Research [email protected] A bill (“Hannah’s Law”) in the New York Assembly would require health insurance policies to cover the cost of enteral formulas for treating eosinophilic esophagitis and related eosinophilic disorders.
    [Show full text]
  • Eye Disease 1 Eye Disease
    Eye disease 1 Eye disease Eye disease Classification and external resources [1] MeSH D005128 This is a partial list of human eye diseases and disorders. The World Health Organisation publishes a classification of known diseases and injuries called the International Statistical Classification of Diseases and Related Health Problems or ICD-10. This list uses that classification. H00-H59 Diseases of the eye and adnexa H00-H06 Disorders of eyelid, lacrimal system and orbit • (H00.0) Hordeolum ("stye" or "sty") — a bacterial infection of sebaceous glands of eyelashes • (H00.1) Chalazion — a cyst in the eyelid (usually upper eyelid) • (H01.0) Blepharitis — inflammation of eyelids and eyelashes; characterized by white flaky skin near the eyelashes • (H02.0) Entropion and trichiasis • (H02.1) Ectropion • (H02.2) Lagophthalmos • (H02.3) Blepharochalasis • (H02.4) Ptosis • (H02.6) Xanthelasma of eyelid • (H03.0*) Parasitic infestation of eyelid in diseases classified elsewhere • Dermatitis of eyelid due to Demodex species ( B88.0+ ) • Parasitic infestation of eyelid in: • leishmaniasis ( B55.-+ ) • loiasis ( B74.3+ ) • onchocerciasis ( B73+ ) • phthiriasis ( B85.3+ ) • (H03.1*) Involvement of eyelid in other infectious diseases classified elsewhere • Involvement of eyelid in: • herpesviral (herpes simplex) infection ( B00.5+ ) • leprosy ( A30.-+ ) • molluscum contagiosum ( B08.1+ ) • tuberculosis ( A18.4+ ) • yaws ( A66.-+ ) • zoster ( B02.3+ ) • (H03.8*) Involvement of eyelid in other diseases classified elsewhere • Involvement of eyelid in impetigo
    [Show full text]
  • Coxiella Burnetii, the Agent of Q Fever in Brazil
    Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 107(5): 695-697, August 2012 695 Coxiella burnetii, the agent of Q fever in Brazil: its hidden role in seronegative arthritis and the importance of molecular diagnosis based on the repetitive element IS1111 associated with the transposase gene Tatiana Rozental1/+, Luis Filipe Mascarenhas2, Ronaldo Rozenbaum2,3, Raphael Gomes1, Grasiely Souza Mattos1, Cecília Carlos Magno4, Daniele Nunes Almeida1, Maria Inês Doria Rossi1, Alexsandra RM Favacho1, Elba Regina Sampaio de Lemos1 1Laboratório de Hantaviroses e Rickettsioses, Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, RJ, Brasil 2Hospital Servidores do Estado, Rio de Janeiro, RJ, Brasil 3Hospital Samaritano, Rio de Janeiro, RJ, Brasil 4Hospital Copa-D’Or, Rio de Janeiro, RJ, Brasil Coxiella burnetii is the agent of Q fever, an emergent worldwide zoonosis of wide clinical spectrum. Although C. burnetii infection is typically associated with acute infection, atypical pneumonia and flu-like symptoms, endo- carditis, osteoarticular manifestations and severe disease are possible, especially when the patient has a suppressed immune system; however, these severe complications are typically neglected. This study reports the sequencing of the repetitive element IS1111 of the transposase gene of C. burnetii from blood and bronchoalveolar lavage (BAL) samples from a patient with severe pneumonia following methotrexate therapy, resulting in the molecular diagnosis of Q fever in a patient who had been diagnosed with active seronegative polyarthritis two years earlier. To the best of our knowledge, this represents the first documented case of the isolation of C. burnetii DNA from a BAL sample. Key words: Q fever - bronchoalveolar lavage - molecular analysis - seronegative polyarthritis - methotrexate Q fever is caused by Coxiella burnetii, a small obli- patients present symptoms of Q fever fatigue syndrome gate intracellular Gram-negative bacterium of the order (QFS), characterised by headache, joint and muscle pain Legionellales (Stein et al.
    [Show full text]
  • European Conference on Rare Diseases
    EUROPEAN CONFERENCE ON RARE DISEASES Luxembourg 21-22 June 2005 EUROPEAN CONFERENCE ON RARE DISEASES Copyright 2005 © Eurordis For more information: www.eurordis.org Webcast of the conference and abstracts: www.rare-luxembourg2005.org TABLE OF CONTENT_3 ------------------------------------------------- ACKNOWLEDGEMENTS AND CREDITS A specialised clinic for Rare Diseases : the RD TABLE OF CONTENTS Outpatient’s Clinic (RDOC) in Italy …………… 48 ------------------------------------------------- ------------------------------------------------- 4 / RARE, BUT EXISTING The organisers particularly wish to thank ACKNOWLEDGEMENTS AND CREDITS 4.1 No code, no name, no existence …………… 49 ------------------------------------------------- the following persons/organisations/companies 4.2 Why do we need to code rare diseases? … 50 PROGRAMME COMMITTEE for their role : ------------------------------------------------- Members of the Programme Committee ……… 6 5 / RESEARCH AND CARE Conference Programme …………………………… 7 …… HER ROYAL HIGHNESS THE GRAND DUCHESS OF LUXEMBOURG Key features of the conference …………………… 12 5.1 Research for Rare Diseases in the EU 54 • Participants ……………………………………… 12 5.2 Fighting the fragmentation of research …… 55 A multi-disciplinary approach ………………… 55 THE EUROPEAN COMMISSION Funding of the conference ……………………… 14 Transfer of academic research towards • ------------------------------------------------- industrial development ………………………… 60 THE GOVERNEMENT OF LUXEMBOURG Speakers ……………………………………………… 16 Strengthening cooperation between academia
    [Show full text]
  • The Clinical Neuropsychiatry of Stroke, Second Edition
    The Clinical Neuropsychiatry of Stroke This fully revised new edition covers the range of neuropsychiatric syndromes associated with stroke, including cognitive, emotional, and behavioral disorders such as depression, anxiety, and psychosis. Since the last edition there has been an explosion of published literature on this topic and the book provides a comprehensive, systematic, and cohesive review of this new material. There is growing recognition among a wide range of clinicians and allied healthcare staff that poststroke neuropsychiatric syndromes are both common and serious. Such complications can have a negative impact on recovery and even survival; however, there is now evidence suggesting that pre-emptive therapeutic intervention in high-risk patient groups can prevent the initial onset of the conditions. This opportunity for primary prevention marks a huge advance in the man- agement of this patient population. This book should be read by all those involved in the care of stroke patients, including psychiatrists, neurologists, rehabilitation specialists, and nurses. Robert Robinson is a Paul W. Penningroth Professor and Head, Department of Psychiatry; Roy J. and Lucille A., Carver College of Medicine, The University of Iowa, IA, USA. The Clinical Neuropsychiatry of Stroke Second Edition Robert G. Robinson cambridge university press Cambridge, New York, Melbourne, Madrid, Cape Town, Singapore, São Paulo Cambridge University Press The Edinburgh Building, Cambridge cb2 2ru,UK Published in the United States of America by Cambridge University Press, New York www.cambridge.org Informationonthistitle:www.cambridge.org/9780521840071 © R. Robinson 2006 This publication is in copyright. Subject to statutory exception and to the provision of relevant collective licensing agreements, no reproduction of any part may take place without the written permission of Cambridge University Press.
    [Show full text]
  • Diseases Transmitted Through the Food Supply
    DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Diseases Transmitted through the Food Supply AGENCY: Centers for Disease Control and Prevention (CDC), Department of Health and Human ­ Services (HHS). ­ ACTION: Notice of annual update of list of infectious and communicable diseases that are ­ transmitted through handling the food supply and the methods by which such diseases are ­ transmitted. ­ SUMMARY: Section 103 (d) of the Americans with Disabilities Act of 1990, Public Law 101–336, ­ requires the Secretary to publish a list of infectious and communicable diseases that are ­ transmitted through handling the food supply and to review and update the list annually. The ­ Centers for Disease Control and Prevention (CDC) published a final list on August 16, 1991 (56 ­ FR40897) and updates on September 8, 1992 (57 FR 40917); January 13, 1994 (59 FR 1949); ­ August 15, 1996 (61 FR 42426); September 22, 1997 (62 FR 49518–9); September 15, 1998 (63 ­ FR 49359); September 21, 1999 (64 FR 51127); September 27, 2000 (65 FR 58088); September ­ 10, 2001 (66 FR 47030); September 27, 2002 (67 FR 61109); September 26, 2006 (71 FR 56152); ­ November 17, 2008 (73 FR 67871); and November 29, 2009 (74 FR 61151). The final list has ­ been reviewed in light of new information and has been revised as set forth below. ­ DATES: Effective Date: January 31, 2014. ­ FOR FURTHER INFORMATION CONTACT: ­ Dr. Art Liang, Division of Foodborne Waterborne and Environment Diseases, National Center for ­ Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), ­ 1600 Clifton Road, NE., Mailstop G–24, Atlanta, Georgia 30333.
    [Show full text]